Human hervesvirus-6 and acute liver failure

被引:43
作者
Härmä, M
Höckerstedt, K
Lautenschlager, I
机构
[1] Univ Helsinki, Cent Hosp, Transplantat & Liver Surg Unit, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Virol, FIN-00029 Helsinki, Finland
关键词
D O I
10.1097/01.TP.0000069233.13409.DF
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background. In patients with acute liver failure (ALF) of unknown cause, viral infections are believed to be involved. This study investigates the involvement of human herpesvirus-6 (HHV-6). Methods. Thirty-two patients with ALF who underwent transplantations during a 6-year period were studied for viruses in biopsies from their explanted livers. Non-A to non-E hepatitis (unknown) ALF was the reason for transplantation in 15 patients, and another 17 patients with a known disease from the same time period served as controls. The explanted livers were examined for hepatitis viruses and other possible viral agents. HHV-6 antigens were demonstrated in the livers and blood mononuclear cells by immunoperoxidase staining. Results. Of the 15 patients with ALF of unknown cause, 12 (80%) demonstrated HHV-6 antigens in the liver. Most of these patients (10/12) also demonstrated HHV-6 antigenemia. The predominant histologic finding of HHV-6 infection was moderate to severe portal lymphocytic infiltration. HHV-6 was found in 4 of 17 control patients, and cytomegalovirus was found in 2 of 17 control patients (in the blood and explanted liver). No other viruses were found in the livers of the patients with ALF. Conclusions. HHV-6 was found in most explanted livers of patients with ALF of unknown cause. HHV-6 antigenemia was associated with HHV-6 antigens in the liver. Only a few control patients displayed HHV-6 in the liver. These observations indicate that HHV-6 may be one of the causes of ALF.
引用
收藏
页码:536 / 539
页数:4
相关论文
共 25 条
[1]
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J].
Adam, R ;
Cailliez, V ;
Majno, P ;
Karam, V ;
McMaster, P ;
Calne, RY ;
O'Grady, J ;
Pichlmayr, R ;
Neuhaus, P ;
Otte, JB ;
Hoeckerstedt, K ;
Bismuth, H .
LANCET, 2000, 356 (9230) :621-627
[2]
ADAM R, 2002, DATA ANAL BOOKLET
[3]
FATAL FULMINANT-HEPATITIS IN AN INFANT WITH HUMAN HERPESVIRUS-6 INFECTION [J].
ASANO, Y ;
YOSHIKAWA, T ;
SUGA, S ;
YAZAKI, T ;
KONDO, K ;
YAMANISHI, K .
LANCET, 1990, 335 (8693) :862-863
[4]
SEVERAL GROUPS AMONG HUMAN HERPESVIRUS-6 STRAINS CAN BE DISTINGUISHED BY SOUTHERN BLOTTING AND POLYMERASE CHAIN-REACTION [J].
AUBIN, JT ;
COLLANDRE, H ;
CANDOTTI, D ;
INGRAND, D ;
ROUZIOUX, C ;
BURGARD, M ;
RICHARD, S ;
HURAUX, JM ;
AGUT, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :367-372
[5]
Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8 [J].
De Clercq, E ;
Naesens, L ;
De Bolle, L ;
Schols, D ;
Zhang, Y ;
Neyts, J .
REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (06) :381-395
[6]
HUMAN HERPESVIRUS-6 (HHV-6) VARIANT-B ACCOUNTS FOR THE MAJORITY OF SYMPTOMATIC PRIMARY HHV-6 INFECTIONS IN A POPULATION OF UNITED-STATES INFANTS [J].
DEWHURST, S ;
MCINTYRE, K ;
SCHNABEL, K ;
HALL, CB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :416-418
[7]
DUBEDAT S, 1989, LANCET, V2, P1463
[8]
Persistence of human herpesvirus 6 according to site and variant: Possible greater neurotropism of variant A [J].
Hall, CB ;
Caserta, MT ;
Schnabel, KC ;
Long, C ;
Epstein, LG ;
Insel, RA ;
Dewhurst, S .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :132-137
[9]
Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan [J].
Ishikawa, K ;
Hasegawa, K ;
Naritomi, T ;
Kanai, N ;
Ogawa, M ;
Kato, Y ;
Kobayashi, M ;
Torii, N ;
Hayashi, N .
JOURNAL OF GASTROENTEROLOGY, 2002, 37 (07) :523-530
[10]
Krueger G R, 1994, In Vivo, V8, P457